Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PDCD1LG2 Antikörper (AA 27-220)

PDCD1LG2 Reaktivität: Human WB, ELISA, FACS, IF, Coat Wirt: Maus Monoclonal PDL2-2676 unconjugated
Produktnummer ABIN6940946
  • Target Alle PDCD1LG2 Antikörper anzeigen
    PDCD1LG2 (Programmed Cell Death 1 Ligand 2 (PDCD1LG2))
    Bindungsspezifität
    • 9
    • 8
    • 7
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 27-220
    Reaktivität
    • 75
    • 31
    • 10
    • 3
    Human
    Wirt
    • 47
    • 31
    • 18
    • 1
    Maus
    Klonalität
    • 49
    • 45
    • 1
    Monoklonal
    Konjugat
    • 51
    • 11
    • 10
    • 8
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PDCD1LG2 Antikörper ist unkonjugiert
    Applikation
    • 48
    • 46
    • 37
    • 30
    • 16
    • 11
    • 9
    • 7
    • 5
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunofluorescence (IF), Coating (Coat)
    Spezifität
    Recognizes a protein of about 31 kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease.
    Aufreinigung
    Purified by Protein A/G
    Immunogen
    Recombinant fragment (around aa 27-220) of human PD-L2 protein (exact sequence is proprietary)
    Klon
    PDL2-2676
    Isotyp
    IgG1 kappa
    Top Product
    Discover our top product PDCD1LG2 Primärantikörper
  • Applikationshinweise

    Positive Control: Jurakt, HepG2, THP-1, RAW, NIH3T3, U87 cells Placenta or Pancreas. Thyroid Carcinoma.

    Known Application: ELISA (For coating, order antibody without BSA),Flow Cytometry (1-2 μg/million cells),Immunofluorescence (1-2 μg/mL),Western Blot (1-2 μg/mL),Optimal dilution for a specific application should be determined.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-80 °C
    Informationen zur Lagerung
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Haltbarkeit
    24 months
  • Target
    PDCD1LG2 (Programmed Cell Death 1 Ligand 2 (PDCD1LG2))
    Andere Bezeichnung
    PDCD1LG2 (PDCD1LG2 Produkte)
    Synonyme
    PDL2 antikoerper, B7DC antikoerper, Btdc antikoerper, CD273 antikoerper, PD-L2 antikoerper, PDCD1L2 antikoerper, bA574F11.2 antikoerper, B7-DC antikoerper, F730015O22Rik antikoerper, programmed cell death 1 ligand 2 antikoerper, PDCD1LG2 antikoerper, Pdcd1lg2 antikoerper
    Molekulargewicht
    31kDa
    Gen-ID
    80380
Sie sind hier:
Kundenservice